Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer

Comparison of the Urinary and Vaginal Auto-takings for the Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02137694

Acronym

PapU-APV

Enrollment

460

Registered

2014-05-14

Start date

2014-04-30

Completion date

2016-10-31

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Research Human Papillomavirus ( HPV) by Vaginal Auto-takings ( APV) and Urinary Test

Keywords

Papillomavirus, Vaginal auto-takings, Urinary test

Brief summary

Auto-takings by APU and vaginal APV during the consultations for FCU in the department of gynecology-obstetrics (Group 1) according to an instructions for use proposed to the inclusive women, with consent; the same proposal, APU and APV, is made for other consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology, ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results transmitted to the women and to the doctors of consultation. In case of positive test (15 %), the patients are directed to a gynecologist. Confrontation with the cytological data when available (Group 1) .

Interventions

OTHERvaginal auto-takings and urinary test

vaginal auto-takings and urinary test

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 65 Years

Healthy volunteers

Inclusion criteria

* All the 25-65-year-old women requiring a screening and seen in consultation of the departments targeted by the CHRU of Brest

Exclusion criteria

* Women except age limit, refusal to participate, hysterectomy, pregnancy and post-therapeutic follow-up.

Design outcomes

Primary

Measure	Time frame	Description
Research for human Papillomavirus by vaginal auto-takings and urinary test	6 months	Estimate the research for human Papillomavirus ( HPV) in the vaginal auto-takings ( APV) and urinary ( APU) test at women from 25 to 65 years old requiring a screening.

Secondary

Measure	Time frame	Description
The global logistic of the study	6 months	Estimate the practicability, the organization of the screening, the follow-up of the women at the Brest Hospital and at Landerneau Hospital

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026